James Yan
Chief Tech/Sci/R&D Officer at ZAI LAB LIMITED
James Yan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ZAI LAB LIMITED | Chief Tech/Sci/R&D Officer | 2020-03-31 | - |
| Chinese Society of Toxicology | Corporate Officer/Principal | - | - |
Career history of James Yan
Former positions of James Yan
| Companies | Position | Start | End |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 2008-12-31 | 2010-12-31 |
Training of James Yan
| Peking Union Medical College | Doctorate Degree |
Statistics
International
| China | 4 |
| Cayman Islands | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Chinese Society of Toxicology |
- Stock Market
- Insiders
- James Yan
- Experience
